Bayer Aktiengesellschaft
BAYZF
$45.41
$1.613.68%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 15.38B | 13.31B | 11.29B | 12.19B | 14.46B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.38B | 13.31B | 11.29B | 12.19B | 14.46B |
| Cost of Revenue | 6.00B | 4.93B | 5.04B | 5.36B | 5.92B |
| Gross Profit | 9.38B | 8.39B | 6.26B | 6.82B | 8.54B |
| SG&A Expenses | 4.24B | 6.25B | 3.98B | 4.27B | 3.90B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -539.37M | -3.22B | 1.16B | -282.60M | 656.66M |
| Total Operating Expenses | 11.33B | 9.45B | 11.93B | 11.06B | 12.01B |
| Operating Income | 4.05B | 3.86B | -634.83M | 1.13B | 2.45B |
| Income Before Tax | 3.43B | -3.93B | -1.36B | -483.48M | 1.93B |
| Income Tax Expenses | 254.76M | 440.03M | -236.16M | -267.84M | 553.53M |
| Earnings from Continuing Operations | 3.18B | -4.37B | -1.12B | -215.64M | 1.37B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -4.59M | -8.15M | -4.68M | -10.21M | -5.26M |
| Net Income | 3.17B | -4.37B | -1.13B | -225.85M | 1.37B |
| EBIT | 4.05B | 3.86B | -634.83M | 1.13B | 2.45B |
| EBITDA | 5.46B | 5.50B | 481.67M | 1.53B | 3.65B |
| EPS Basic | 3.23 | -4.45 | -1.15 | -0.23 | 1.39 |
| Normalized Basic EPS | 2.18 | 3.42 | -0.87 | 0.40 | 1.22 |
| EPS Diluted | 3.22 | -4.45 | -1.15 | -0.23 | 1.39 |
| Normalized Diluted EPS | 2.18 | 3.42 | -0.87 | 0.40 | 1.22 |
| Average Basic Shares Outstanding | 982.42M | 982.42M | 982.42M | 982.42M | 982.42M |
| Average Diluted Shares Outstanding | 982.42M | 982.42M | 982.42M | 982.42M | 982.42M |
| Dividend Per Share | -- | 0.13 | -- | -- | -- |
| Payout Ratio | -- | -- | -0.83% | -54.27% | -- |